Stay updated on Grapiprant and Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Grapiprant and Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Grapiprant and Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Added a site revision note: v3.5.0 and removed the previous revision note: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T17:44:11.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3. No study data or essential content appears to be affected.
    Difference
    0.1%
    Check dated 2026-03-11T14:48:02.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added; the previous 'Notice about government funding' and 'Revision: v3.4.1' items were removed.
    Difference
    0.4%
    Check dated 2026-02-11T01:33:19.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding was added, informing users that information may not be up to date and directing them to opm.gov for updates. The page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-03T22:24:44.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    This update adds a glossary option and standardizes capitalization of metadata labels (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data') along with a new Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T20:01:45.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    Revision update from v3.3.3 to v3.3.4; no visible changes to study content or page functionality detected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-20T13:55:36.000Z thumbnail image

Stay in the know with updates to Grapiprant and Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Grapiprant and Pembrolizumab in NSCLC Clinical Trial page.